Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Oruka Therapeutics PE Ratio 2010-2024 | ORKA

Current and historical p/e ratio for Oruka Therapeutics (ORKA) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Oruka Therapeutics PE ratio as of September 13, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
  
Oruka Therapeutics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-09-13 24.89 0.00
2024-06-30 27.94 $-0.46 0.00
2023-12-31 12.40 $-0.37 0.00
2023-09-30 14.66 $-0.37 0.00
2023-06-30 14.81 $-0.43 0.00
2023-03-31 14.52 $-0.55 0.00
2022-12-31 17.29 $-0.69 0.00
2022-09-30 15.03 $-1.01 0.00
2022-06-30 18.16 $-1.18 0.00
2022-03-31 16.78 $-1.30 0.00
2021-12-31 15.68 $-1.40 0.00
2021-09-30 21.59 $-1.61 0.00
2021-06-30 25.46 $-1.61 0.00
2021-03-31 26.62 $-2.00 0.00
2020-12-31 29.25 $-2.50 0.00
2020-09-30 32.24 $-2.58 0.00
2020-06-30 48.29 $-3.01 0.00
2020-03-31 20.35 $-3.42 0.00
2019-12-31 41.65 $-4.45 0.00
2019-09-30 39.02 $-5.56 0.00
2019-06-30 53.39 $-6.78 0.00
2019-03-31 49.05 $-8.33 0.00
2018-12-31 43.79 $-10.07 0.00
2018-09-30 73.52 $-14.39 0.00
2018-06-30 73.00 $-19.42 0.00
2018-03-31 65.57 $-27.34 0.00
2017-12-31 177.24 $-32.37 0.00
2017-09-30 150.98 $-34.53 0.00
2017-06-30 315.10 $-36.69 0.00
2017-03-31 334.79 $-33.81 0.00
2016-12-31 374.18 $-32.37 0.00
2016-09-30 371.55 $-29.14 0.00
2016-06-30 380.74 $-25.54 0.00
2016-03-31 455.58 $-30.39 0.00
2015-12-31 610.50 $-39.56 0.00
2015-09-30 651.20 $-142.62 0.00
2015-06-30 1056.89 $-150.89 0.00
2015-03-31 726.13 $-138.44 0.00
2014-12-31 876.39 $-135.92 0.00
2014-09-30 1139.61 $-44.19 0.00
2024-03-31 12.84 $-30.35 0.00
2014-06-30 1341.79 $-50.35 0.00
2014-03-31 1709.41 $-118.31 0.00
2013-12-31 1543.98 $-146.00 0.00
2013-09-30 1470.46 $-183.76 0.00
2013-06-30 1185.56 $-215.22 0.00
2013-03-31 2187.31 $-133.41 0.00
2012-12-31 2095.40 $-179.96 0.00
2012-09-30 1909.02 $-255.46 0.00
2012-06-30 2646.83 $-332.21 0.00
2012-03-31 5017.94 $-309.56 0.00
2011-12-31 5514.22 $-407.71 0.00
2011-09-30 6175.93 $-430.36 0.00
2011-06-30 8877.90 $-483.21 0.00
2011-03-31 14061.27 $-702.17 0.00
2010-12-31 17480.09 $-755.02 0.00
2010-09-30 21009.19 $-1,268.43 0.00
2010-06-30 18913.78 $-1,517.59 0.00
2010-03-31 30052.51 $-2,182.00 0.00
2009-12-31 17976.37 $-875.82 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.030B $0.000B
Oruka Therapeutics Inc. is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka Therapeutics Inc., formerly known as ARCA biopharma Inc., is based in WESTMINSTER, Colo.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $86.574B 34.49
Takeda Pharmaceutical (TAK) Japan $46.774B 9.36
Merck (MKGAF) Germany $24.944B 27.22
Summit Therapeutics (SMMT) United States $23.134B 0.00
Astellas Pharma (ALPMY) Japan $21.734B 26.11
Sandoz Group AG (SDZNY) Switzerland $17.865B 0.00
United Therapeutics (UTHR) United States $15.088B 15.59
Shionogi (SGIOY) Japan $13.202B 12.65
Neurocrine Biosciences (NBIX) United States $12.344B 36.93
Catalent (CTLT) United States $10.819B 0.00
Orion OYJ (ORINY) Finland $7.373B 30.02
Revolution Medicines (RVMD) United States $7.300B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.718B 7.12
Ionis Pharmaceuticals (IONS) United States $6.169B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.660B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.250B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.306B 0.00
Corcept Therapeutics (CORT) United States $3.982B 33.73
Dyne Therapeutics (DYN) United States $3.420B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.672B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.668B 15.39
PTC Therapeutics (PTCT) United States $2.615B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.400B 19.08
Soleno Therapeutics (SLNO) United States $2.054B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.925B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.847B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.639B 0.00
Harrow (HROW) United States $1.602B 0.00
Ardelyx (ARDX) United States $1.486B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.437B 0.00
Ocular Therapeutix (OCUL) United States $1.403B 0.00
Indivior (INDV) United States $1.365B 6.27
Cassava Sciences (SAVA) United States $1.349B 0.00
Xencor (XNCR) United States $1.326B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.319B 0.00
ARS Pharmaceuticals (SPRY) United States $1.289B 0.00
Evotec AG (EVO) Germany $1.254B 0.00
Collegium Pharmaceutical (COLL) United States $1.208B 6.93
Calliditas Therapeutics AB (CALT) Sweden $1.199B 0.00
Enliven Therapeutics (ELVN) United States $1.054B 0.00
Relay Therapeutics (RLAY) United States $1.018B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.005B 0.00
Bioventus (BVS) United States $0.904B 29.40
4D Molecular Therapeutics (FDMT) United States $0.845B 0.00
Cronos Group (CRON) Canada $0.833B 0.00
USANA Health Sciences (USNA) United States $0.732B 13.43
Ironwood Pharmaceuticals (IRWD) United States $0.730B 45.70
ProKidney (PROK) United States $0.692B 0.00
Savara (SVRA) United States $0.691B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.672B 0.00
Exscientia (EXAI) United Kingdom $0.608B 0.00
Pacira BioSciences (PCRX) United States $0.605B 5.72
Eliem Therapeutics (ELYM) United States $0.567B 0.00
Siga Technologies (SIGA) United States $0.564B 6.75
Altimmune (ALT) United States $0.560B 0.00
Silence Therapeutics (SLN) United Kingdom $0.559B 0.00
Foghorn Therapeutics (FHTX) United States $0.538B 0.00
OmniAb (OABI) United States $0.533B 0.00
Tourmaline Bio (TRML) United States $0.494B 0.00
KalVista Pharmaceuticals (KALV) United States $0.481B 0.00
Sage Therapeutics (SAGE) United States $0.478B 0.00
Verve Therapeutics (VERV) United States $0.465B 0.00
Larimar Therapeutics (LRMR) United States $0.459B 0.00
Aquestive Therapeutics (AQST) United States $0.441B 0.00
Xeris Biopharma Holdings (XERS) United States $0.429B 0.00
Zevra Therapeutics (ZVRA) United States $0.413B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.398B 0.00
Korro Bio (KRRO) United States $0.385B 0.00
Elite Pharmaceuticals (ELTP) United States $0.385B 36.01
Esperion Therapeutics (ESPR) United States $0.375B 0.00
Organogenesis (ORGO) United States $0.373B 0.00
Aldeyra Therapeutics (ALDX) United States $0.358B 0.00
Black Diamond Therapeutics (BDTX) United States $0.350B 0.00
Lexeo Therapeutics (LXEO) United States $0.320B 0.00
Lyell Immunopharma (LYEL) United States $0.315B 0.00
Akebia Therapeutics (AKBA) United States $0.307B 0.00
ESSA Pharma (EPIX) Canada $0.304B 0.00
Heron Therapeutics (HRTX) United States $0.284B 0.00
Acrivon Therapeutics (ACRV) United States $0.276B 0.00
Avita Medical (RCEL) United States $0.267B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.263B 0.00
Nature's Sunshine Products (NATR) United States $0.260B 17.80
Nektar Therapeutics (NKTR) United States $0.241B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.241B 0.00
Nanobiotix S.A (NBTX) France $0.233B 0.00
Pyxis Oncology (PYXS) United States $0.223B 0.00
MediWound (MDWD) Israel $0.191B 0.00
Profound Medical (PROF) Canada $0.189B 0.00
Innate Pharma SA (IPHYF) France $0.184B 0.00
CytoDyn (CYDY) United States $0.183B 0.00
Telomir Pharmaceuticals (TELO) United States $0.180B 0.00
Galectin Therapeutics (GALT) United States $0.179B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.178B 0.00
VAXART, INC (VXRT) United States $0.175B 0.00
Cardiol Therapeutics (CRDL) Canada $0.173B 0.00
Context Therapeutics (CNTX) United States $0.157B 0.00
Achieve Life Sciences (ACHV) Canada $0.156B 0.00
Prelude Therapeutics (PRLD) United States $0.152B 0.00
OptiNose (OPTN) United States $0.136B 0.00
Century Therapeutics (IPSC) United States $0.136B 0.00
Fractyl Health (GUTS) United States $0.134B 0.00
Assertio Holdings (ASRT) United States $0.116B 20.33
CASI Pharmaceuticals (CASI) China $0.111B 0.00
Journey Medical (DERM) United States $0.107B 0.00
Regulus Therapeutics (RGLS) United States $0.105B 0.00
Incannex Healthcare (IXHL) Australia $0.103B 0.00
Metagenomi (MGX) United States $0.101B 0.00
Karyopharm Therapeutics (KPTI) United States $0.095B 0.00
Citius Pharmaceuticals (CTXR) United States $0.094B 0.00
Relmada Therapeutics (RLMD) United States $0.093B 0.00
AlloVir (ALVR) United States $0.087B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.084B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.083B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Arch Biopartners (ACHFF) Canada $0.076B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.00
Vivani Medical (VANI) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.056B 0.00
SCYNEXIS (SCYX) United States $0.055B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Nutriband (NTRB) United States $0.050B 0.00
FibroGen (FGEN) United States $0.047B 0.00
DURECT (DRRX) United States $0.047B 0.00
ProPhase Labs (PRPH) United States $0.047B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.044B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.041B 0.00
Inotiv (NOTV) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Protara Therapeutics (TARA) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.039B 0.00
Gain Therapeutics (GANX) United States $0.037B 0.00
Unicycive Therapeutics (UNCY) United States $0.037B 0.00
Tempest Therapeutics (TPST) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.036B 0.00
Enlivex Therapeutics (ENLV) Israel $0.034B 0.00
Surrozen (SRZN) United States $0.028B 0.00
VYNE Therapeutics (VYNE) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.025B 0.00
Lipocine (LPCN) United States $0.025B 0.00
TherapeuticsMD (TXMD) United States $0.021B 0.00
Minerva Neurosciences (NERV) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.020B 0.77
BioVie (BIVI) United States $0.019B 0.00
NRx Pharmaceuticals (NRXP) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Indaptus Therapeutics (INDP) United States $0.015B 0.00
Talphera (TLPH) United States $0.015B 0.00
Aptorum Group (APM) United Kingdom $0.015B 0.00
Nuvilex (PMCB) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Conduit Pharmaceuticals (CDT) United States $0.013B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Vivos Therapeutics (VVOS) United States $0.010B 0.00
Viracta Therapeutics (VIRX) United States $0.010B 0.00
Avalo Therapeutics (AVTX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
Ainos (AIMD) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (BGM) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 3.56
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 35.69